Insider Transactions in Q1 2021 at Charles River Laboratories International, Inc. (CRL)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 29
2021
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-17.14%
|
$247,780
$260.88 P/Share
|
|
Jan 29
2021
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,162
+36.25%
|
-
|
|
Jan 29
2021
|
David Ross Smith Corporate Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,795
-17.78%
|
$986,700
$260.88 P/Share
|
|
Jan 29
2021
|
David Ross Smith Corporate Executive VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,234
+40.01%
|
-
|
|
Jan 29
2021
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Payment of exercise price or tax liability
|
Direct |
4,708
-20.55%
|
$1,224,080
$260.88 P/Share
|
|
Jan 29
2021
|
Joseph W La Plume EVP, Corp Strategy & Develop |
BUY
Grant, award, or other acquisition
|
Direct |
11,862
+34.12%
|
-
|
|
Jan 29
2021
|
James C Foster Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
32,753
-11.3%
|
$8,515,780
$260.88 P/Share
|
|
Jan 29
2021
|
James C Foster Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,129
+20.58%
|
-
|
|
Jan 25
2021
|
David Ross Smith Corporate Executive VP & CFO |
BUY
Bona fide gift
|
Indirect |
8,656
+50.0%
|
-
|
|
Jan 25
2021
|
David Ross Smith Corporate Executive VP & CFO |
SELL
Bona fide gift
|
Direct |
8,656
-54.9%
|
-
|
|
Jan 14
2021
|
James C Foster Chairman, President and CEO |
SELL
Bona fide gift
|
Direct |
3,500
-1.6%
|
-
|
|
Jan 04
2021
|
David Ross Smith Corporate Executive VP & CFO |
SELL
Open market or private sale
|
Direct |
5,000
-2.26%
|
$1,245,000
$249.34 P/Share
|